Results of Bladder-Conserving Treatment, Consisting of Brachytherapy Combined With Limited Surgery and External Beam Radiotherapy, for Patients With Solitary T1-T3 Bladder Tumors Less Than 5 cm in Diameter

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2, 2007, Pages 454-458

  Blank, Leo E C M ^a   Koedooder, Kees ^a   van Os, Rob ^a   van de Kar, Marlou ^a   van der Veen, J Haitze ^b   Koning, Caro C E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Kennemer Gasthuis ^*  (Netherlands)

Author keywords

Bladder cancer; Brachytherapy

Indexed keywords

BIOLOGICAL ORGANS; PATIENT MONITORING; RADIOTHERAPY; SURGERY; TOXICITY;

BLADDER CANCER; BRACHYTHERAPY; TUMOR CONTROL;

ONCOLOGY;

ADULT; AGED; ARTICLE; BLADDER; BLADDER CANCER; BLADDER TUMOR; BRACHYTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; ILEUS; LUNG EMBOLISM; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SURGICAL TECHNIQUE; TOXICITY; WOUND DEHISCENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 34548498436     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.03.014     Document Type: Article

References (20)

1. De Neve W., Lybeert M.L., Goor C., et al. T1 and T2 carcinoma of the urinary bladder: Long term results with external, preoperative, or interstitial radiotherapy. Int J Radiat Oncol Biol Phys 23 (1992) 299-304
2. Pernot M., Hubert J., Guillemin F., et al. Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192). Radiother Oncol 38 (1996) 115-120
3. Pos F., Horenblas S., Dom P., et al. Organ preservation in invasive bladder cancer: Brachytherapy, an alternative to cystectomy and combined modality treatment?. Int J Radiat Oncol Biol Phys 61 (2005) 678-686
4. Rozan R., Albuisson E., Donnarieix D., et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 24 (1992) 469-477
5. van der Steen-Banasik E.M., Visser A.G., Reinders J.G., et al. Saving bladders with brachytherapy: Implantation technique and results. Int J Radiat Oncol Biol Phys 53 (2002) 622-629
6. Wijnmaalen A., and Boeken Kruger C.C. Organ preservation by external beam and afterloading interstitial radiation in patients with muscle infiltrating bladder cancer. Semin Urol Oncol 18 (2000) 308-312
7. Sobin L.H. TNM, sixth edition: New developments in general concepts and rules. Semin Surg Oncol 21 (2003) 19-22
8. van der Werf Messing B., Menon R.S., and Hop W.C. Cancer of the urinary bladder category T2,T3 (NxM0) treated by interstitial radium implant: Second report. Int J Radiat Oncol Biol Phys 9 (1983) 481-485
9. González González D., Van der Veen J.H., Ypma A.F., et al. Braquiterapia en el cáncer d vejiga urinaria. Arch Esp Urol 52 (1999) 655-661
10. Visser O., Nieuwenhuijzen J.A., and Horenblas S. Local recurrence after cystectomy and survival of patients with bladder cancer: A population based study in greater Amsterdam. J Urol 174 (2005) 97-102
11. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20 (2002) 3061-3071
12. Zietman A.L., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: Management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58 (2001) 380-385
13. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
14. Coppin C.M., Gospodarowicz M.K., James K., et al., for the National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
15. Schaake-Koning C., van den Bogaert W., Dalesio O., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
16. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 358 (2001) 781-786
17. Pignon J.P., Bourhis J., Domenge C., et al., for the MACH-NC (Meta-Analysis of Chemotherapy on Head and Neck Cancer) Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
18. Kuczyk M., Turkeri L., Hammerer P., et al. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?. Eur Urol 44 (2003) 57-64
19. Nieuwenhuijzen J.A., Pos F., Moonen L.M., et al. Survival after bladder-preservation with brachytherapy versus radical cystectomy: A single institution experience. Eur Urol 48 (2005) 239-245
20. Henningsohn L., Steven K., Kallestrup E.B., et al. Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol 168 (2002) 168-174